Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) · children undergoing neurodiagnostic procedures
1 finding from 1 review
Proportion of children who had sedation failure or inadequate level of sedation · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) showed no clear difference in proportion of children who had sedation failure or inadequate level… compared with sodium thiopental rectal (25 mg/kg) (moderate certainty).
1 finding from 1 review
Sedation duration (minutes) · children undergoing neurodiagnostic procedures
1 finding from 1 review
Number of children with clinical adverse event: oxygen desaturation · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) showed no clear difference in number of children with clinical adverse event: desaturation compared with sodium thiopental rectal (25 mg/kg) (low certainty).
1 finding from 1 review
Number of children with clinical adverse event: diarrhoea · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) probably leads to lower number of children with clinical adverse event: diarrhoea compared with sodium thiopental rectal (25 mg/kg) (moderate certainty).
1 finding from 1 review
Diastolic blood pressure · children undergoing neurodiagnostic procedures
1 finding from 1 review
Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) · children undergoing neurodiagnostic procedures
1 finding from 1 review
Bradycardia · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) leads to lower number of children with clinical adverse event: bradycardia compared with dexmedetomidine intranasal (3 μg/kg) (high certainty).
1 finding from 1 review
Number of children with clinical adverse event: unsteadiness within 24 h after discharge · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) showed no clear difference in number of children with clinical adverse event: unsteadiness within… compared with dexmedetomidine intranasal (3 μg/kg) (low certainty).
1 finding from 1 review
Number of children with clinical adverse event: crying during administration of sedation · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) probably leads to higher number of children with clinical adverse event: crying during… compared with dexmedetomidine intranasal (3 μg/kg) (moderate certainty).
1 finding from 1 review
Vomiting · children undergoing neurodiagnostic procedures
Chloral hydrate oral (50 mg/kg) showed no clear difference in number of children with clinical adverse event: vomiting compared with dexmedetomidine intranasal (3 μg/kg) (low certainty).
1 finding from 1 review
Proportion of children who successfully completed neurodiagnostic procedure without interruption by the child awakening · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of children who required a further dose of either the same sedative agent or the addition of a different sedative agent · children undergoing neurodiagnostic procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to adequate sedation (minutes or as measured by specific validated scales such as the Ramsay Sedation Score) · children undergoing neurodiagnostic procedures
1 finding from 1 review
OLT and VSC scores · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
1 finding from 1 review
Volatile sulphur compounds (VSC), gas chromatography · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
Protease cysteine + actinidine tablets showed no clear difference in volatile sulphur compounds (VSC), OralChroma compared with placebo tablets; GRADE not reported.
1 finding from 1 review
Volatile sulphur compounds (VSC), gas chromatography · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
1 finding from 1 review
Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' · women with endometriosis
2 findings from 1 review
Self‐reported pain: menstrual pain reduction from baseline to end of treatment · women with endometriosis
1 finding from 1 review
Self‐reported pain (dysmenorrhoea) at the end of treatment (continuous data): dysmenorrhoea at 6 months' · women with endometriosis
2 findings from 1 review